GGrantIndex
Sort

50,496 grants matching lung cancer

Role of KAT5 in lung cancer

$399,154
Susumu Kobayashi · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA

Ultra-precision diagnostics for ALK+ non-small cell lung cancer

$399,153
David Randall Armant · Alelopharma Inc. · R43 · FY2025 · CA

Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer

$399,133
Ming Hui Chen · Duke University · R01 · FY2024 · CA

Targeting DDX3 for triple-negative breast cancer treatment

$399,129
Venu Raman · Johns Hopkins University · R21 · FY2025 · CA

Role of the SWI/SNF complex in tumor suppression

$399,112
Charles W Roberts · St. Jude Children'S Research Hospital · R01 · FY2020 · CA

A fully automated tool for more accurate malignancy assessment in pulmonary nodules from chest CT

$399,112
Joshua Reicher · Imvaria Inc. · R43 · FY2025 · CA

Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening

$399,100
Lisa Carter-Bawa · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Role of type 2 immune response in pancreatic cancer tumorigenesis

$399,058
Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA

PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in Mice

$399,051
Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2021 · CA

Arsenic and Nickel Carcinogenesis in Human Lung Cells

$399,035
Max Costa · New York University School Of Medicine · R01 · FY2022 · ES

Role of the ABC Transporter ABCB6 in Cytotoxicity

$399,022
John D Schuetz · St. Jude Children'S Research Hospital · R01 · FY2006 · ES

BIOMOLECULAR ANALYSIS USING LIQUID CRYSTALS

$399,019
Nicholas L Abbott · University Of Wisconsin-Madison · R01 · FY2011 · CA

Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches

$399,013
Keith Syson Chan · Cedars-Sinai Medical Center · R01 · FY2020 · CA

Role of the SWI/SNF complex in tumor suppression

$399,004
Charles W Roberts · St. Jude Children'S Research Hospital · R01 · FY2021 · CA

Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy

$399,000
Evripidis Gavathiotis · Albert Einstein College Of Medicine · R01 · FY2021 · CA

The B7x pathways in the tumor microenvironment

$399,000
Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2025 · CA

Advancing cancer therapy: Developing antibody blockade targeting a novel immune checkpoint, LAIR1/CD305

$398,997
Jianping Huang · Immunogenik, Inc. · R41 · FY2025 · CA

Environmental Pathology Training Grant

$398,990
Brooke Taylor Mossman · University Of Vermont & St Agric College · T32 · FY2009 · ES

Use of senolytics to enhance chemotherapeutic efficacy in lung cancer

$398,989
David A. Gewirtz · Virginia Commonwealth University · R01 · FY2021 · CA

Use of senolytics to enhance chemotherapeutic efficacy in lung cancer

$398,989
David A. Gewirtz · Virginia Commonwealth University · R01 · FY2020 · CA

Use of senolytics to enhance chemotherapeutic efficacy in lung cancer

$398,989
David A. Gewirtz · Virginia Commonwealth University · R01 · FY2019 · CA

Project 1:Evolutionary dynamics and drivers of breast cancer metastasis and relapse

$398,968
Christina N Curtis · Stanford University · U54 · FY2022 · CA

N-cadherin in Extraskeletal Osteolineage Cells Modulates Tumor Growth

$398,949
Roberto Civitelli · Washington University · R01 · FY2021 · CA

MicroRNA Cellular Functions and Target Identification in Acute Myeloid Leukemia

$398,947
Elizabeth Mambo · Ambion Diagnostics, Inc. · R43 · FY2006 · CA

NKX2-1, A Candidate Lineage Survival Oncogene in Lung Adenocarcinoma

$398,913
Matthew L Meyerson · Dana-Farber Cancer Inst · R01 · FY2013 · CA